Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
- Posted on August 4, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
